P105 Treatment options in patients with metastatic castrate-resistant prostate cancer (mCRPC) previously treated with a docetaxel-containing regimen: A single UK cancer centre's experience using patients within the early access programme and cancer drugs fund
Hague, C.J., Kelly, C.L.S., Cornthwaite, S.A., Birtle, A.J.Volume:
12
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(13)62430-6
Date:
November, 2013
File:
PDF, 65 KB
english, 2013